In this study, the low-risk group demonstrated increased infiltration of immune cells, such as CD8+T cells, adipocytes, basophils, Tgd cells, Th1 cells, cancer-associated fibroblasts, and activated dendritic cells, compared to the high-risk group, indicating a stronger anti-cancer immune response. The gene discussed is CD8A; the disease is cancer.